Editas Medicine Inc (EDIT) financials · rev $40.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Editas Medicine Inc (EDIT) rev $40.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $40.5M | $32.3M |
| Operating Income | -$160.0M | -$251.2M |
| Net Income | -$160.1M | -$237.1M |
| EPS (Diluted) | -$1.80 | -$2.88 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $186.5M | $341.6M |
| Current Assets | $163.9M | $289.3M |
| Cash & Equivalents | $146.6M | $131.5M |
| PP&E | $3.54M | $14.5M |
| Total Liabilities | $159.2M | $207.3M |
| Current Liabilities | $46.2M | $77.2M |
| Short-term Debt | $5.00M | $5.00M |
| Long-term Debt | $53.6M | $52.4M |
| Total Debt | $58.6M† | $57.4M† |
| Shareholders' Equity | $27.3M | $134.3M |
| Retained Earnings | -$1.63B | -$1.47B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$165.2M | -$210.3M |
| CapEx | $607.0K | $8.83M |
| Investing Cash Flow | $138.7M | $162.1M |
| Financing Cash Flow | $40.5M | $56.0M |
| Net Change in Cash | $13.9M | $7.89M |
| Free Cash Flow | -$165.8M | -$219.1M |
FAQ
What is EDIT P/E and revenue?
Editas Medicine Inc (EDIT) rev $40.5M.
What is EDIT revenue?
Editas Medicine Inc last cached revenue is $40.5M (FY2025).
Is EDIT profitable?
Editas Medicine Inc last cached net income is -$160.1M (FY2025).
What are EDIT total assets?
Editas Medicine Inc last cached total assets are $186.5M (FY2025).
What is EDIT free cash flow?
Editas Medicine Inc last cached free cash flow is -$165.8M (FY2025).
Not investment advice. Cached statements, not a live tape.